Antidote
SEPTEMBER 21, 2022
September 21 is World Alzheimer’s Day , a day of recognition aimed at increasing awareness of and understanding the issues faced by people living with Alzheimer’s. Though there are many conditions that can cause memory loss , Alzheimer’s is one of the most common — it is estimated that 5.4 million Americans are living with the condition , most of whom are over the age of 65.
Drug Patent Watch
SEPTEMBER 22, 2022
This chart shows the patent expirations for film dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…. The post Film dosed drug patent expirations by year appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
SEPTEMBER 20, 2022
On October 11, 2022, Drug Channels Institute will release The 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This report—our thirteenth edition— remains the most comprehensive, fact-based tool for understanding and analyzing the large and growing U.S. pharmaceutical distribution industry. We are providing you with the opportunity to preorder this thoroughly updated and revised 2022-23 edition at special discounted prices.
Advarra
SEPTEMBER 23, 2022
The Food and Drug Administration (FDA) is the federal entity in the U.S. charged with (among other things) “ensur[ing] that safe and effective drugs are available to improve the health of the people in the United States.” . Before the FDA permits a pharmaceutical drug product to be lawfully marketed, sponsors are required to submit information about the product’s safety and efficacy so the FDA can determine : .
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Crown Bioscience
SEPTEMBER 22, 2022
Modern high-content imaging (HCI) and analysis platforms provide simultaneous multi-parameter visualization and quantification of thousands of cells including 3D in vitro models. This highly comprehensive information provides deep insights into the mechanisms of action, toxicity, and synergistic and off-target effects of single and combinations of compounds.
Drug Patent Watch
SEPTEMBER 21, 2022
This chart shows the drugs with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…. The post Which pharmaceutical drugs have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Olympian Clinical Research
SEPTEMBER 22, 2022
It is estimated that about 14% of the population will experience onychomycosis, more commonly known as toenail fungus, at some point in their lives. Toenail fungus may affect people of all ages, but it is more common in adults over 60. Furthermore, it can quickly spread to other toenails if left untreated. This all-inclusive guide will teach you everything you need to know about toenail fungus, from identifying the symptoms to exploring treatment options.
ProRelix Research
SEPTEMBER 21, 2022
According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, with a death rate of one in six in 2020 (1). Aside from the high […]. The post Cancer Clinical Trials: USA Scenario and Study Designs appeared first on ProRelix Research.
Drug Patent Watch
SEPTEMBER 23, 2022
This chart shows the pharmaceutical companies with the most patents in China. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in China? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Channels
SEPTEMBER 21, 2022
The battle for control of the specialty patient continues. In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. However, buy-and-bill appears to have rebounded substantially at hospitals. As I explain below, this resurgence likely reflects the success of vertically-integrated hospital/specialty pharmacy/physician mega-systems against the large insurer/PBM/specialty pharmacy/provi
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Translation
SEPTEMBER 19, 2022
Like most startups, Halo looks much different today than it did when we started, but the problem we’re solving hasn’t changed — there are thousands of scientific discoveries that never materialize into real-world solutions. At first, we tried to solve this problem by crowdfunding research projects to help leapfrog these nascent technologies over the so-called “valley of death.
sptlabtech
SEPTEMBER 20, 2022
Researchers need biobanks to provide high-quality samples via optimal processing, secure storage, and preservation under the appropriate conditions for the lifetime of the sample. Fundamental to the success of a biobank is the ability to preserve high-quality samples for many decades. Automated storage solutions offer both quantitative and more intangible benefits to the biobank workflow, such as integrated sample traceability, secure storage, increased retrieval speed, and sample preservation.
Drug Patent Watch
SEPTEMBER 20, 2022
This chart shows the pharmaceutical companies with the most patents in Czech Republic. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…. The post Which pharmaceutical companies have the most drug patents in Czech Republic? appeared first on DrugPatentWatch - Make Better Decisions.
Antidote
SEPTEMBER 20, 2022
Sickle cell disease (SCD) refers to a genetically inherited set of red blood cell disorders that are present from birth. Millions of people are impacted by SCD each year, but it disproportionately impacts Black and African American populations, occurring in about 1 out of every 365 Black or African-American births.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Advarra
SEPTEMBER 20, 2022
Site selection for clinical trials is often one of the biggest headaches for pharmaceutical sponsors and contract research organizations (CROs). Even with enough due diligence, activated sites can still fail to recruit the desired number of study participants. Reliable industry estimates peg the cost of these under-accruing sites to the pharmaceutical industry at between $600,000 to eight million dollars per day of trial delay.
National Institute on Drug Abuse: Nora's Blog
SEPTEMBER 19, 2022
Addiction often goes hand-in-hand with other mental illnesses. Both must be addressed. mfleming Mon, 09/19/2022 - 19:50 Nora's Blog September 27, 2022 Image ©Getty Images/ PeopleImages This op-ed was originally published by The Hill on September 12, 2022 Natalie struggled with a methamphetamine use disorder for more than 9 years. She was one of the fortunate few to receive treatment to address her addiction, yet that help felt incomplete.
Drug Patent Watch
SEPTEMBER 23, 2022
Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent for Sprout Pharms drug ADDYI appeared first on DrugPatentWatch - Make Better Decisions.
Drug & Device Law
SEPTEMBER 19, 2022
Under Wyeth v. Levine, 555 U.S. 555 (2009) , and PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011) , failure-to-warn claims targeting a pharmaceutical are preempted unless the manufacturer could have provisionally changed its warning label without prior FDA approval under the “changes being effected” (“CBE”) provision codified at 21 C.F.R. § 314.70(c)(6)(iii)(A).
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drug Patent Watch
SEPTEMBER 23, 2022
Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug. SLYND drug…. The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 23, 2022
Annual Drug Patent Expirations for DROSPIRENONE Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs Ltd, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs,…. The post New patent for Exeltis Usa drug DROSPIRENONE appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 23, 2022
Annual Drug Patent Expirations for VABOMERE Vabomere is a drug marketed by Rempex and is included in one NDA. It is available from one supplier. There are six patents protecting…. The post New patent for Rempex drug VABOMERE appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 22, 2022
Annual Drug Patent Expirations for BETHKIS Bethkis is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are three patents protecting…. The post New patent expiration for Chiesi drug BETHKIS appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 21, 2022
Annual Drug Patent Expirations for ZUBSOLV Zubsolv is a drug marketed by Orexo Us Inc and is included in one NDA. It is available from one supplier. There are nine…. The post New patent for Orexo Us drug ZUBSOLV appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 21, 2022
Annual Drug Patent Expirations for VELPHORO Velphoro is a drug marketed by Vifor Fresenius and is included in one NDA. It is available from one supplier. There are ten patents…. The post New patent for Vifor Fresenius drug VELPHORO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 21, 2022
Annual Drug Patent Expirations for JATENZO Jatenzo is a drug marketed by Clarus and is included in one NDA. It is available from one supplier. There are eight patents protecting…. The post New patent for Clarus drug JATENZO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 21, 2022
Annual Drug Patent Expirations for OXLUMO Oxlumo is a drug marketed by Alnylam Pharms Inc and is included in one NDA. There are twelve patents protecting this drug. This drug…. The post New patent for Alnylam Pharms drug OXLUMO appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 19, 2022
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Finland. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…. The post Which pharmaceutical companies have the most SPCs in Finland? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 18, 2022
This chart shows the drug companies with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the…. The post Which pharma companies have the most supplementary protection certificates? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 17, 2022
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…. The post Which drugs have the most supplementary protection certificates? appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 17, 2022
Annual Drug Patent Expirations for DEXYCU+KIT Dexycu Kit is a drug marketed by Eyepoint Pharms and is included in one NDA. There are six patents protecting this drug. This drug…. The post New patent for Eyepoint Pharms drug DEXYCU KIT appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 17, 2022
Annual Drug Patent Expirations for VAGIFEM Vagifem is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from one supplier. There is one…. The post New patent expiration for Novo Nordisk drug VAGIFEM appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 17, 2022
Annual Drug Patent Expirations for PHEXXI Phexxi is a drug marketed by Evofem Inc and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent for Evofem Inc drug PHEXXI appeared first on DrugPatentWatch - Make Better Decisions.
Drug Patent Watch
SEPTEMBER 17, 2022
Annual Drug Patent Expirations for ZYNRELEF+KIT Zynrelef Kit is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are…. The post New patent for Heron Theraps drug ZYNRELEF KIT appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
97 
Let's personalize your content